73 percent of psychiatrists say reimbursement restriction of Zyprexa is improper

73 percent of psychiatrists said the reimbursement restriction of Zyprexa (olanzapine), schizophrenia medication, is unfair, a survey showed recently.

According to a survey conducted on 100 psychiatrists nationwide by the Research International commissioned by Lilly Korea during three days (September 16-18)), 73 percent of the surveyed doctors answered that the government's mandatory decisio...